NCT06115447 is a clinical trial of lung suturing with polyglactin in Lung Injury, sponsored by Assiut University.

Who is sponsoring NCT06115447?

NCT06115447 is sponsored by Assiut University.

What drugs are being tested in NCT06115447?

Interventions in NCT06115447: lung suturing with polyglactin, ung suturing with polypropylene.

What condition does NCT06115447 study?

NCT06115447 studies Lung Injury, Bleb Lung, Lung Cancer.

Is NCT06115447 still recruiting?

NCT06115447 is currently not yet recruiting. Last updated 3 November 2023.

Last reviewed 2023-11-03 · How we verify

NCT06115447

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Polypropylene vs Polyglactin in Suturing of the Lung

Not yet recruiting Last updated 3 November 2023

What this trial tests

trial testing lung suturing with polyglactin in Lung Injury in 100 participants. Not yet recruiting.

Timeline

15 April 2024

Primary endpoint
30 April 2026

30 October 2028

Quick facts

Lead sponsor	Assiut University
Status	Not yet recruiting
Study type	OBSERVATIONAL
Enrollment	100
Start date	15 April 2024
Primary completion	30 April 2026
Estimated completion	30 October 2028

Drugs / interventions tested

lung suturing with polyglactin
ung suturing with polypropylene

Conditions studied

Lung Injury — all drugs for Lung Injury →
Bleb Lung — all drugs for Bleb Lung →
Lung Cancer — all drugs for Lung Cancer →

Sponsor

Assiut University

Who can join

Adults 18 to 65, any sex, with Lung Injury or Bleb Lung. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Comparative study comparing polypropylene and Polyglactin in suturing of the lung

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Lung Injury

Currently open trials in the same condition.

NCT06296173 — Open Lung Protective Extubation Following General Anesthesia · NA · recruiting
NCT06528418 — Identification of Multiple Pulmonary Diseases Using Volatile Organic Compounds Biomarkers in Human Exhaled Breath · recruiting
NCT05642832 — Feasibility of Reducing Respiratory Drive Using the Through-flow System · NA · recruiting
NCT06203405 — The Efficacy of P0.1-guided Sedation Protocol in Critically Ill Patients Receiving Invasive Mechanical Ventilation: A Ra · NA · recruiting
NCT06416709 — Stem Cell Treatment for Lung Injury Caused by Major Infectious Diseases · Phase 1, PHASE2 · recruiting

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06115447 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 3 November 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06115447.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing